The COVID-19 epidemic has triggered action from every government agency, including the U.S. Food and Drug Administration (FDA). Charged with, among other things, ensuring the safety and efficacy of drugs and medical devices, the FDA has taken steps to both accelerate the biotech and life sciences industry's work to test, diagnose and treat COVID-19 as well as rein in misguided or unscrupulous COVID-19 products.